- Home
- / East Midlands Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
East Midlands Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
£13 M
FY, 2019
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
|---|---|---|---|---|
| Revenue | 12.1M | 15.6M | 14.1M | 13.0M |
| Revenue growth, % | -1.0% | 29.0% | -9.8% | |
| Cost of goods sold | 10.2M | 13.5M | 12.3M | 10.3M |
| Gross profit | 1.9M | 2.1M | 1.8M | 2.6M |
| Gross profit margin, % | 15.7% | 13.2% | 12.6% | 20.4% |
| Operating expense total | 1.5M | 2.0M | 2.4M | 2.6M |
| EBITDA | 530.6K | 276.5K | (407.9K) | 190.6K |
| EBITDA margin, % | 4.4% | 1.8% | -2.9% | 1.5% |
| EBIT | 372.5K | 57.8K | (611.5K) | 30.6K |
| EBIT margin, % | 3.1% | 0.4% | -4.4% | 0.2% |
| Pre tax profit | 218.3K | (31.1K) | (675.2K) | (49.0K) |
| Income tax expense | 24.2K | (7.4K) | 121.8K | 2.0K |
| Net Income | 194.1K | (23.7K) | (553.3K) | (47.1K) |